Profilo
Peter Olofsson is the founder of Redoxis AB, founded in 2007, holding the title of Director.
Dr. Olofsson is currently the Chief Executive Officer of ProNoxis AB since 2012.
Former positions include Principal at Biovitrum AB and Principal at Arexis AB. Education includes a doctorate from the University of Lund and an MBA from the University of Gothenburg.
Posizioni attive di Jan Peter Olofsson
| Società | Posizione | Inizio |
|---|---|---|
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Fondatore | 01/01/2007 |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Amministratore Delegato | - |
Precedenti posizioni note di Jan Peter Olofsson
| Società | Posizione | Fine |
|---|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Direttore/Membro del Consiglio | 31/12/2009 |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formazione di Jan Peter Olofsson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Develops preclinical drug and validates autoimmune diseases, with expertise in In Vivo models | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Health Technology |
















